anmelden
BX Swiss TOP 30 CHF
1.485,60
PKT
-2,98
PKT
-0,20
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 21.01.05 | Zurich Insurance Buy | Sarasin Research | |
| 21.01.05 | Holcim Accumulate | Helvea | |
| 21.01.05 | Zurich Insurance Accumulate | Helvea | |
| 20.01.05 | Logitech Buy | Sarasin Research | |
| 20.01.05 | Holcim Halten | Helaba Trust | |
| 20.01.05 | Zurich Insurance Buy | Sarasin Research | |
| 20.01.05 | Logitech Buy | Sarasin Research | |
| 20.01.05 | Holcim Neutral | Sarasin Research | |
| 20.01.05 | Swiss Life Buy | M.M. Warburg | |
| 20.01.05 | UBS Buy | Sarasin Research | |
| 20.01.05 | Novartis Hold | SEB | |
| 21.01.05 | Logitech Accumulate | Helvea | |
| 21.01.05 | Holcim Accumulate | Helvea | |
| 20.01.05 | Lindt Underperform | Goldman Sachs | |
| 20.01.05 | Richemont Outperform | Goldman Sachs | |
| 20.01.05 | Novartis Neutral | Sarasin Research | |
| 21.01.05 | Lindt Neutral | Sarasin Research | |
| 20.01.05 | Novartis Akkumulieren | Independent Research | |
| 21.01.05 | Novartis Buy | Helvea | |
| 19.01.05 | Novartis Equal-weight | Morgan Stanley | |
| 19.01.05 | Holcim In-Line | Goldman Sachs | |
| 20.01.05 | Logitech In-Line | Goldman Sachs | |
| 21.01.05 | Novartis Kaufen | Helaba Trust | |
| 19.01.05 | Zurich Insurance Overweight | Lehman Brothers | |
| 19.01.05 | Givaudan Neutral | Sarasin Research | |
| 19.01.05 | Nestlé In-Line | Goldman Sachs | |
| 19.01.05 | Straumann Accumulate | Helvea | |
| 21.01.05 | Nestlé Kaufen | Helaba Trust | |
| 18.01.05 | Novartis Buy | AG Edwards | |
| 18.01.05 | Novartis Outperform | Bear Stearns | |
| 18.01.05 | Novartis Buy | Merrill Lynch | |
| 18.01.05 | Roche Buy | Merrill Lynch | |
| 18.01.05 | Nestlé Buy | Helvea | |
| 18.01.05 | Novartis Buy | Merrill Lynch | |
| 18.01.05 | Lonza Buy | Helvea | |
| 18.01.05 | Novartis Buy | Sarasin Research | |
| 24.01.05 | Swiss Life Neutral | Sal. Oppenheim | |
| 18.01.05 | Novartis Akkumulieren | Independent Research | |
| 18.01.05 | Richemont Overweight | Lehman Brothers | |
| 20.01.05 | Zurich Insurance Outperform | Goldman Sachs |